HPM Partners »

ADC Therapeutics SA shares owned by HPM Partners

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by HPM Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $29k 27k 1.07
2025-03-31 $25k 18k 1.41

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
Procter & Gamble Company (PG)
Eli Lilly & Co. (LLY)

View all positions for HPM Partners

Top funds holding ADC Therapeutics SA

Nantahala Capital Management
Redmile Group
TCG Crossover Management
Prosight Management
BlackRock
Morgan Stanley
Point72 Asset Management
Millennium Management
Citadel Advisors
Goldman Sachs Group
State Street Corporation
Geode Capital Management
Bank of America Corporation
Vanguard Portfolio Management
Two Sigma Investments

View all funds holding ADC Therapeutics SA